Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer-Reference-Cited by-同舟云学术

Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer

Published:2020-11 Issue:6 Volume:5 Page:1213-1224
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Imber Brandon S.,Varghese Melissa,Goldman Debra A.,Zhang Zhigang,Gewanter Richard,Marciscano Ariel E.,Mychalczak Borys,Gorovets Daniel,Kollmeier Marisa,McBride Sean M.,Zelefsky Michael J.

Funder

National Institute of Health

National Cancer Institute Cancer Center

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference50 articles.

1. De novo metastatic castration sensitive prostate cancer: State of art and future perspectives;Mosillo;Cancer Trea. Rev,2018

2. Past, current, and future incidence rates and burden of metastatic prostate cancer in the United States;Kelly;Eur Urol Focus,2018

3. Characterization of differences between prostate cancer patients presenting with de novo versus primary progressive metastatic disease;Finianos;Clin Genitourin Cancer,2018

4. Characterization of patients who present with de novo metastatic prostate cancer: Single-institution database analysis;Strock;J Clin Oncol,2013

5. Age, race, and survival of men with de novo distant metastatic prostate cancer (M1PC);Bernard;J Clin Oncol,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05);Practical Radiation Oncology;2024-09

2. Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review;European Urology Oncology;2024-07

3. Protocol for Evaluating the Efficacy and Safety of Radiotherapy for Prostate and Oligometastatic Lesions in Patients With Low-Burden Sensitive Oligometastatic Prostate Cancer: An Open, Exploratory Pilot Clinical Trial;Cancer Control;2024-01

4. Real‐world evidence of outcomes of oligometastatic hormone‐sensitive prostate cancer patients treated with metastasis‐directed therapy;The Prostate;2023-07-18

5. Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancer;World Journal of Urology;2023-06-16